Cardiovascular safety of etoricoxib

Cardiovascular safety of etoricoxib

Meticulous attention is paid to the cardiovascular safety of nonsteroidal anti-inflammatory drugs (NSAIDs), the so-called selective cyclooxy-genase 2 (COX-2) inhibitors in particular. The author considers precisely this matter in case of Russia's recent NSAID etoricoxib that has been tested alo...

Full description

Bibliographic Details
Main Authors:	Viktoriya Georgievna Barskova, Viktoria Georgiyevna Barskova
Format:	Article
Language:	Russian
Published:	IMA-PRESS LLC 2011-09-01
Series:	Современная ревматология
Subjects:	nonsteroidal anti-inflammatory drugs cardiovascular safety etoricoxib
Online Access:	https://mrj.ima-press.net/mrj/article/view/371

Similar Items

Etoricoxib (arcoxia) in rheumatology
by: Fatima Magomedovna Kudaeva, et al.
Published: (2011-06-01)

Etoricoxib (arcoxia) in rheumatology
by: Fatima Magomedovna Kudaeva, et al.
Published: (2011-06-01)

ETORICOXIB: THERAPEUTIC POTENTIAL
by: A. E. Karateev
Published: (2009-03-01)

What does a study of nonsteroidal anti-inflammatory drug sales statistics give the Russian Federation?
by: Viktoriya Georgievna Barskova, et al.
Published: (2011-09-01)

The therapeutic potential of etoricoxib in clinical practice
by: A. E. Karateev
Published: (2020-03-01)

Use of etoricoxib in patients with gout in real clinical practice
by: M S Eliseyev, et al.
Published: (2013-06-01)

Comparison of clinical efficacy and safety of original and generic forms of etoricoxib in patients with knee osteoarthritis
by: M.O. Korzh, et al.
Published: (2024-03-01)

Efficiency and safety of different etoricoxib regimens in patients with axial spondyloarthritis, including ankylosing spondylitis
by: I Z Gaydukova, et al.
Published: (2015-03-01)

MELOXICAM: WHAT DO WE KNOW ABOUT CARDIOVASCULAR SAFETY?
by: M S Eliseev, et al.
Published: (2010-03-01)

Etoricoxib can be used for chronic nonspecific back pain: a new indication of the well-known drug
by: A. E. Karateev
Published: (2020-04-01)

Etoricoxib in the treatment of osteoarthritis
by: S. G. Anikin, et al.
Published: (2020-03-01)

Symptom modifiers in therapy for ankylosing spondylitis
by: V. V. Badokin
Published: (2010-06-01)

Efficacy of short term non steroidal anti-inflammatory drugs in Indian patients with axial spondyloarthritis
by: Shubha Bhalla, et al.
Published: (2018-01-01)

Etoricoxib in the treatment of active sacroiliitis in patients with axial spondyloarthritis, including ankylosing spondylitis
by: I Z Gaĭdukova, et al.
Published: (2014-12-01)

Fixed Drug Eruption with Pigmentation Induced by Etoricoxib: A Case Report
by: Dextre-Vilchez, Sergio Armando, et al.
Published: (2025-01-01)

The problem of cardiac safety of nonsteroidal anti-inflammatory drugs
by: N A Shostak, et al.
Published: (2016-05-01)

Clinico-pharmacological aspects of choice and safety of NSAIDs in patients with cerebrovascular disease against a background of rheumatoid arthritis
by: I. A. Zolotovskaya, et al.
Published: (2014-12-01)

Pharmacokinetic equivalence study of nonsteroidal anti-inflammatory drug etoricoxib
by: Tjandrawinata RR, et al.
Published: (2018-04-01)

Patients with cardiovascular diseases and NSAIDs use: real clinical practice
by: A. P. Rebrov, et al.
Published: (2021-01-01)

A case of wet purpura due to etoricoxib induced thrombocytopenia
by: Robin George Manappallil
Published: (2016-08-01)

The peripheral and central mechanisms of transition of acute to chronic pain and the possible role of cyclooxygenase-2 inhibition in the prevention of pain syndrome chronization
by: O. S. Davydov
Published: (2016-07-01)

NEW DATA ON THE SAFETY OF NONSTEROIDAL ANTI-INFLAMMATORY DRUGS: THE CONCEPT OF THE HIGH CLASS-SPECIFIC CARDIOVASCULAR RISK OF SELECTIVE CYCLOOXYGENASE-2 INHIBITORS IS OUTDATED
by: A. E. Karateev, et al.
Published: (2017-04-01)

DEVELOPMENT AND VALIDATION THE METHOD OF QUANTITATIVE DETERMINATION OF ETORICOXIB IN SOLID PHARMACEUTICAL FORMS BY HPLC
by: T. L. Batalova, et al.
Published: (2019-01-01)

Etoricoxib‐induced pleural effusion: A case report
by: Bishal Kumar Sah, et al.
Published: (2023-11-01)

A case of toxic epidermal necrolysis probably due to etoricoxib
by: Sayanta Thakur, et al.
Published: (2019-01-01)

Etoricoxib Coated Tablets: Bioequivalence Assessment between Two Formulations Administered under Fasting Conditions
by: Jessica Meulman, et al.
Published: (2023-11-01)

Nonsteroidal anti-inflammatory drugs: What is new in international publications in 2015?
by: A. E. Karateev, et al.
Published: (2016-03-01)

Etoricoxib-Cannabidiol Combo: Potential Role in Glioblastoma Treatment and Development of PLGA-Based Nanoparticles
by: Joanna Kuźmińska, et al.
Published: (2023-08-01)

Multimodal Analgesia Approach in Acute Low Back Pain Management: A Phase III Study of a Novel Analgesic Combination of Etoricoxib/Tramadol
by: Miguel A. Zuqui-Ramírez, et al.
Published: (2024-09-01)

Complete form of pachydermoperiostosis with good initial response to etoricoxib: A case report
by: Abinash Baniya, et al.
Published: (2023-06-01)

What is new? An overview of the 2016 international publications on the efficacy and safety of nonsteroidal anti-inflammatory drugs
by: A. E. Karateev
Published: (2017-03-01)

Facet joint osteoarthritis as a component of non-specific low back pain
by: O. S. Davydov
Published: (2019-06-01)

Comparative evaluation of the safety and efficacy of etoricoxib and diclofenac on the upper gastrointestinal tract in patients with osteoarthrosis and rheumatoid arthritis (the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) study program)
by: L I Alekseyeva
Published: (2010-08-01)

Comparative analysis of the effect of diclofenac sodium and etoricoxib on energy metabolism in rat liver in the acute general cooling model
by: S.Yu. Shtrygol’, et al.
Published: (2022-12-01)

Non-Steroidal Anti-Inflammatory Drug Etoricoxib Facilitates the Application of Individualized Exercise Programs in Patients with Ankylosing Spondylitis
by: Iulia Rahela Marcu, et al.
Published: (2020-05-01)

Analgesia na entorse de tornozelo: estudo com etoricoxibe
by: Rogério Teixeira da Silva, et al.

USE OF NONSTEROIDAL ANTI-INFLAMMATORY DRUGS IN PATIENTS WITH HIGH CARDIOVASCULAR RISK
by: Yu. A. Olyunin
Published: (2017-07-01)

Do etoricoxib and indometacin have similar effects and safety for gouty arthritis? A meta-analysis of randomized controlled trials
by: Lin TM, et al.
Published: (2018-12-01)

Synthesis of zinc oxide based etoricoxib and montelukast nanoformulations and their evaluation through analgesic, anti-inflammatory, anti-pyretic and acute toxicity activities
by: Sulaiman Sulaiman, et al.
Published: (2022-06-01)

Effect of non-steroidal anti-inflammatory drug etoricoxib on the hematological parameters and enzymes of colon and kidney Efecto del fármaco antiinflamatorio no esteroideo etoricoxib sobre los parámetros hematológicos y las enzimas del colon y el riñón
by: N. Behal, et al.
Published: (2009-06-01)